Top

Published in:

01-06-2011 | Colorectal Cancer

2010 Staging System for Colon and Rectal Carcinoma

Authors: J. Milburn Jessup, MD, Leonard L. Gunderson, MD, Frederick L. Greene, MD, Mary Kay Washington, MD, Carolyn C. Compton, MD, PhD, Leslie H. Sobin, MD, Bruce Minsky, MD, Richard M. Goldberg, MD, Stanley R. Hamilton, MD

Published in: Annals of Surgical Oncology | Issue 6/2011

Excerpt

The American Joint Committee on Cancer (AJCC) has partnered with the Annals of Surgical Oncology to publish a series of editorials that highlight revisions in staging criteria for major cancer types from the recently published 7th edition of the AJCC Cancer Staging Manual.1 Cancer registrars nationwide are now using these updates. This editorial, which focuses on the staging system for colorectal carcinoma, is the sixth in a series designed to outline the revisions of specific staging systems for the Annals of Surgical Oncology readership. …

Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.

Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP. American joint committee on cancer prognostic factors consensus conference: colorectal working group. Cancer. 2000;88:1739–57.PubMedCrossRef

Shepherd N, Baxter K, Love S. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology. 1997;112:1096–102.PubMedCrossRef

Zeng Z, Cohen AM, Hajdu S, et al. Serosal cytologic study to determine free mesothelial penetration of intraperitoneal colon cancer. Cancer. 1992;70:737–40.PubMedCrossRef

Vogel P, Ruschoff J, Kummel S, et al. Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer. Dis Colon Rectum. 2000;43:92–100.PubMedCrossRef

Greene FL, Page DL, Fleming ID, et al. Colon and rectum. In: Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual. 6th ed. New York: Springer; 2002. p. 113–24.CrossRef

Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart A. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol. 2010;28:256-63.PubMedCrossRef

Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2010;28:264–71.PubMedCrossRef

Ryan R, Gibbons D, Hyland JMP, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47:141–6.PubMedCrossRef

10.

Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26:303–12.PubMedCrossRef

11.

Cecil TD, Sexton R, Moran BJ, Heald RJ. Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum. 2004;47:1145–9.PubMedCrossRef

12.

Wittekind C, Compton C, Quirke P, Nagtegaal I, Merkel S, Hermanek P, Sobin LH. A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status. Cancer. 2009;115:3483–8.PubMedCrossRef

13.

Allegra CJ, Jessup JM, Somerfield MR, et al. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol. 2009;27:2091–6.PubMedCrossRef

14.

Italiano A, Hostein I, Soubeyran I, et al. KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications. Ann Surg Oncol. 2010;17:1429–34.PubMedCrossRef

15.

Russo A, Bazan V, Agnese V, et al. Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. Ann Oncol. 2005;16(Suppl 4):iv44–9.

16.

Alberts SR, Sargent DJ, Smyrk TC, et al. Adjuvant mFOLFOX6 with or without cetuximab (Cmab) in KRAS wild-type (WT) patients (pts) with resected stage III colon cancer (CC): results from NCCTG Intergroup Phase III Trial N0147. Proc Am Soc Clin Oncol. (Abstract #CRA3507). 2010 ASCO annual meeting.

17.

Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 1993;260:816–9.PubMedCrossRef

18.

Watanabe T, Wu TT, Catalano PJ, et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med. 2001;344:1196–206.PubMedCrossRef

19.

Sargent DJ, Marsoni S, Monges G, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010;28:3219–26.PubMedCrossRef

20.

Bertagnolli MB, Niedzwiecki D, Compton CC, et al. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: cancer and leukemia. J Clin Oncol. 2009;27:1814–21.PubMedCrossRef

21.

Samowitz WS, Sweeney C, Herrick J, et al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 2005;65:6063–9.PubMedCrossRef

22.

Roth AD, Tejpar S, Delorenzi M, et al. Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J Clin Oncol. 2010:28:466–74.PubMedCrossRef

23.

Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006;24:3726–34.PubMedCrossRef

24.

D. Kerr, R. Gray, P. Quirke, et al. A quantitative multigene RT-PCR assay for prediction of recurrence in stage II colon cancer: selection of the genes in four large studies and results of the independent, prospectively designed QUASAR validation study [abstract 4000]. J Clin Oncol. 2009;27(Suppl):15s.

25.

Wu AH, Drees JC, Wang H, et al. Gene expression profiles help identify the tissue of origin for metastatic brain cancers. Diagn Pathol. 2010;5:26.PubMedCrossRef

26.

Wang Y, Jatkoe T, Zhang Y, et al. Gene expression profiles and molecular markers to predict recurrence of Dukes’ B colon cancer. J Clin Oncol. 2004;22:1564–71.PubMedCrossRef

27.

Smith JJ, Deane NG, Wu F, et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 2010;138:958–68.PubMedCrossRef

Title: 2010 Staging System for Colon and Rectal Carcinoma
Authors: J. Milburn Jessup, MD
Leonard L. Gunderson, MD
Frederick L. Greene, MD
Mary Kay Washington, MD
Carolyn C. Compton, MD, PhD
Leslie H. Sobin, MD
Bruce Minsky, MD
Richard M. Goldberg, MD
Stanley R. Hamilton, MD
Publication date: 01-06-2011
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 6/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-010-1360-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

2010 Staging System for Colon and Rectal Carcinoma

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2011

4D Parathyroid CT as the Initial Localization Study for Patients with De Novo Primary Hyperparathyroidism

Surgical Cytoreduction and Survival in Appendiceal Cancer Peritoneal Carcinomatosis: An Evaluation of 46 Consecutive Patients

Tumor Volume Increase During Preoperative Chemotherapy as a Novel Predictor of Local Recurrence in Extremity Osteosarcoma

Multifocality in “Basal-Like” Breast Carcinomas and its Influence on Lymph Node Status

Tissue hOGG1 Genotype Predicts Bladder Cancer Prognosis: A Novel Approach Using a Peptide Nucleic Acid Clamping Method

Importance of the First Postoperative Year in the Prognosis of Elderly Colorectal Cancer Patients